Related Experiment Videos
Etoposide-related myocardial infarction
C L Airey1, D J Dodwell, J K Joffe
1Cookridge Hospital, Leeds, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|January 1, 1995
Summary
A man experienced a myocardial infarction (heart attack) after etoposide chemotherapy. This case highlights a potential link between this cancer treatment and cardiac events, even without traditional risk factors.
Area of Science:
- Cardiology
- Oncology
- Pharmacology
Background:
- Chemotherapy regimens are essential in cancer treatment.
- Etoposide is a commonly used chemotherapy agent.
- Coronary heart disease risk factors are well-established.
Observation:
- A case of myocardial infarction (heart attack) is presented.
- The event occurred in a patient undergoing chemotherapy.
- The patient had no prior risk factors for coronary heart disease.
Findings:
- The patient received chemotherapy containing etoposide.
- A myocardial infarction was diagnosed post-chemotherapy.
- This suggests a potential adverse cardiac effect of etoposide.
Implications:
- Etoposide may contribute to myocardial infarction in susceptible individuals.
- Further research into the cardiotoxicity of etoposide is warranted.
- Clinicians should consider cardiac monitoring in patients receiving etoposide, especially those without traditional risk factors.